Table 1. Cell densities for DMSO carrier control and apoptosis inhibitor injection protocols.
2 d injection | Origin | Midsubstance | Insertion | 5 d injection | Origin | Midsubstance | Insertion | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Apoptotic cell density (cells/mm2) | 7 d | DMSO | 127.4 ± 54.5C | 136.5 ± 116.8d | 272.3 ± 200.6 | Apoptotic cell density (cells/mm2) | 7 d | DMSO | 53.5 ± 54.lC | 40.8 ± 67.4d | 121.3 ± 194.4 |
Drug | 250.6 ± 286.4e | 171.5 ± 204.0 | 292.9 ± 272.6f | Drug | 39.4 ± 44.3e | 32.3 ± 25.1 | 91.3 ± 76.6f | ||||
14 d | DMSO | 69.2 ± 28.5a | 51.5 ± 28.3B | 112.8 ± 58.2g | 14 d | DMSO | 51.5 ± 26.6 | 40.6 ± 29.5 | 53.8 ± 57.1g | ||
Drug | 250.1 ± 243.6aH | 122.4 ± 75.1BI | 229.6 ± 226.3 | Drug | 47.8 ± 37.5H | 40.9 ± 30.4I | 125.5 ± 125.7 | ||||
Live cell density (cells/mm2) | 7 d | DMSO | 586.1 ± 133.9 | 737.3 ± 244.8jN | 948.6 ± 345.3 | Live cell density (cells/mm2) | 7 d | DMSO | 563.3 ± 204.8 | 471.8 ± 106.9LN | 853.6 ± 129.1M |
Drug | 536.9 ± 388.4 | 531.8 ± 149.8jP | 870.7 ± 487.2 | Drug | 557.9 ± 271.6 | 782.6 ± 248.9LP | 1182.8 ± 326.9M | ||||
14 d | DMSO | 809.6 ± 241.6k | 599.8 ± 248.9 | 1169.9 ± 353.5 | 114 d | DMSO | 638.5 ± 203.8 | 639.6 ± 137.9 | 1078.2 ± 105.2 | ||
Drug | 508.3 ± 276.1kq | 583.9 ± 144.2 | 888.6 ± 440.4 | Drug | 745.5 ± 201.0q | 564.9 ± 169.0 | 1141.6 ± 464.3 | ||||
Total cell density (cells/mm2) | 7 d | DMSO | 724.0 ± 147.3 | 873.8 ± 320.7T | 1223.7 ± 404.7 | Total cell density (cells/mm2) | 7 d | DMSO | 616.8 ± 202.1 | 512.6 ± 102.9RT | 981.4 ± 176.3s |
Drug | 793.4 ± 306.8 | 703.4 ± 143.2 | 1163.7 ± 249.3 | Drug | 598.4 ± 268.4 | 814.9 ± 236.3R | 1254.1 ± 330.3s | ||||
114 d | DMSO | 878.8 ± 230.9 | 651.4 ± 270.3 | 1282.7 ± 390.2 | 14 d | DMSO | 690.1 ± 221.8 | 680.2 ± 136.6 | 1134.1 ± 99.6 | ||
Drug | 758.3 ± 250.6 | 706.4 ± 123.6 | 1121.1 ± 414.4 | Drug | 795.7 ± 190.2 | 605.9 ± 188.8 | 1267.7 ± 387.8 |